Atlas Trials

Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia

Clinical trial NCT06374290 · TERMINATED

Trial details

NCT number
NCT06374290
Sponsor
The University of Texas Health Science Center, Houston
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2024-07-16
Primary completion
2024-12-04
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.